People: DBV Technologies SA (DBV.PA)

DBV.PA on Paris Stock Exchange

21 Sep 2018
Change (% chg)

€1.02 (+2.49%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Benhamou, Pierre-Henri 

Dr. Pierre-Henri Benhamou has been appointed as Chairman of the Board, Chief Executive Officer of the Company,, effective November 1, 2015. He was Chief Scientific Officer of DBV Technologies SA since January 17, 2012. He served as Chairman of the Board, Chief Executive Officer, Chief Scientific Officer between February 25, 2010 and December 23, 2010. He is the co-founder of the Company. He was first appointed on the Company’s Board of Directors on December 23, 2005. He is a former Interne des Hopitaux and former Chief of Clinic. He is specialized in pediatric gastroenterology and has held a number of senior clinical positions after studying Pediatrics in Paris and Amiens. In 1989, Dr. Benhamou created the Centre for Digestive Exploration of Infants at the Surgical Clinic in Boulogne-Billancourt. Dr. Benhamou received the Prize for Innovation from the Altran Foundation in 2003 for his work on the development of patch tests for the diagnosis of cow’s milk proteins allergy.

Basic Compensation

Total Annual Compensation, EUR 355,630
Restricted Stock Award, EUR --
Long-Term Incentive Plans, EUR --
All Other, EUR --
Fiscal Year Total, EUR 355,630

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --